Skip to main content

Aisling Capital LLC

13F filer · CIK 0001571076
Last filed Nov 13, 2019
Inactive · not filing 13F
13F portfolio value$45.3MU.S. long equity reported on 13F
Positions51 new · 0 closed
Net flow last quarter-$16MBuys minus sells
Top 10 positions weight100.0%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q3 2019Reported Nov 13, 20195 positions
AIMTAimmune Therapeutics, Inc.$26M57.34%1.97%-37.7%Q3 2015
ADMAAdma Biologics, Inc.$16.1M35.46%6.08%Not reportedQ4 2014
CDTXCidara Therapeutics, Inc.$1.78M3.93%2.70%-12.7%Q3 2015
TRXCAsensus Surgical, Inc.$1.48M3.27%Not reportedNot reportedQ2 2014
VRAYViewRay, Inc.$00.00%0.02%Not reportedQ1 2016
Q2 2019Reported Aug 8, 20194 positions
AIMTAimmune Therapeutics, Inc.$41.4M68.67%3.18%Not reportedQ3 2015
ADMAAdma Biologics, Inc.$14M23.14%6.08%Not reportedQ4 2014
TRXCAsensus Surgical, Inc.$3.23M5.35%Not reportedNot reportedQ2 2014
CDTXCidara Therapeutics, Inc.$1.72M2.84%3.81%Not reportedQ3 2015
Q1 2019Reported May 7, 20194 positions
AIMTAimmune Therapeutics, Inc.$44.5M66.84%3.19%Not reportedQ3 2015
ADMAAdma Biologics, Inc.$13.7M20.55%7.78%Not reportedQ4 2014
TRXCAsensus Surgical, Inc.$5.69M8.55%Not reportedNot reportedQ2 2014
CDTXCidara Therapeutics, Inc.$2.71M4.07%3.83%Not reportedQ3 2015
Q4 2018Reported Feb 11, 20196 positions
LOXOLoxo Oncology, Inc.$286M80.87%6.66%Not reportedQ3 2014
AIMTAimmune Therapeutics, Inc.$47.6M13.48%3.20%Not reportedQ3 2015
ADMAAdma Biologics, Inc.$8.62M2.44%7.78%Not reportedQ4 2014
TRXCAsensus Surgical, Inc.$5.4M1.53%Not reportedNot reportedQ2 2014
CDTXCidara Therapeutics, Inc.$2.4M0.68%3.67%Not reportedQ3 2015
VRAYViewRay, Inc.$2.21M0.62%0.38%-79.1%Q1 2016
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.